Simplex Trading, LLC Summit Therapeutics Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$1.32 - $2.81 $16,734 - $35,625	12,678 Added 101.95%	25,114 $63,000
Q1 2023 Apr 27, 2023	SELL	$1.38 - $5.41 $4,268 - $16,733	-3,093 Reduced 19.92%	12,436 $21,000
Q4 2022 Feb 02, 2023	BUY	$0.68 - $5.31 $10,559 - $82,458	15,529 New	15,529 $65,000
Q2 2022 Aug 03, 2022	BUY	$0.92 - $2.38 $57 - $149	63 New	63 $0
Q1 2022 May 02, 2022	SELL	$2.0 - $3.45 $3,156 - $5,444	-1,578 Closed	0 $0

Q4 2021 Feb 23, 2022	SELL	$2.45 - $5.64 $1,487 - $3,423	-607 Reduced 27.78%	1,578 $4,000
Q3 2021 Oct 28, 2021	SELL	$4.83 - $8.27 $3,530 - $6,045	-731 Reduced 25.07%	2,185 $17,000
Q2 2021 Aug 12, 2021	BUY	$5.15 - $8.46 $15,017 - $24,669	2,916 New	2,916 $21,000

107

41.3M

103K

29.9K

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.52B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.